TLDR Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.
The study on albendazole treatment for echinococcosis in 20 patients found that the drug inhibited microsomal enzyme function and induced its own metabolism, leading to decreased plasma levels of albendazole sulfoxide in some patients. Significant side effects included hepatotoxicity, neutropenia, and alopecia, with 50% of patients experiencing hair loss and one case of total alopecia. The findings underscored the importance of close therapeutic monitoring due to the substantial incidence of adverse effects.
2 citations,
January 2020 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)” The drug Albendazole, used for treating parasites, can cause sudden hair loss.
5 citations,
December 2022 in “Annals Academy of Medicine Singapore” Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.
42 citations,
January 2021 in “Journal of Clinical Medicine” Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.
7 citations,
September 2013 in “Current Dermatology Reports” Some skin medications are safe for pregnant women, but others pose risks or should not be used.
83 citations,
May 1999 in “International Journal of Dermatology” Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.
